SUBJECTS : Genomic Profiling | Genetics | Pharmacology | Drug Metabolis
Pharmacogenomics and Personalized Medicine: 2023, vol: 16, issue:
- 1)- Rui Huang, Yi-Ting Zhang, Yu Lin, Ru-Li Pang, Zhi Yang, Wei-Hua Zhao. Clinical Characteristics and Prognosis of Acute Myeloid Leukemia Patients with Protein Tyrosine Phosphatase Non-Receptor Type 11 Gene Mutation. Pharmacogenomics and personalized medicine. 2023, 16: 1011-1026
Cited : 0Read More - 2)- Lei Meng, Jun Cao, Li Kang, Gang Xu, Da-Wei Yuan, Kang Li, Kun Zhu. Implication of KDR Polymorphism rs2071559 on Therapeutic Outcomes and Safety of Postoperative Patients with Gastric Cancer Who Received S-1-Based Adjuvant Chemotherapy: A Real-World Exploratory Study. Pharmacogenomics and personalized medicine. 2023, 16: 1027-1039Cited : 0Read More
- 3)- Yuanfeng Zhang, Yang Chen, Zhiming Chen, Xinye Zhou, Shaochuan Chen, Kaijian Lan, Zhiping Wang, Yonghai Zhang. Identification of P3H1 as a Predictive Prognostic Biomarker for Bladder Urothelial Carcinoma Based on the Cancer Genome Atlas Database. Pharmacogenomics and personalized medicine. 2023, 16: 1041-1053Cited : 1Read More
- 4)- Hanbing Song, Hongpeng Liu, XiaoDong Li, Bing Lv, Zonghan Tang, Qipeng Chen, Danqi Zhang, Fei Wang. Novel Autophagy-Related Blood Biomarkers Associated with Immune Cell Infiltration in Ankylosing Spondylitis. Pharmacogenomics and personalized medicine. 2023, 16: 1055-1066Cited : 0Read More
- 5)- Miao Zhou, Wenyan Wang, Jiahao Weng, Zhikun Lai. A Review on Probable Causes of Cardiotoxicity Caused by Common Cancer Drugs and the Role of Traditional Chinese Medicine in Prevention and Treatment. Pharmacogenomics and personalized medicine. 2023, 16: 1067-1077Cited : 0Read More
- 6)- Yu Ma, Jinbo Gao, Hongning Guo. Circ_0000140 Alters miR-527/SLC7A11-Mediated Ferroptosis to Influence Oral Squamous Cell Carcinoma Cell Resistance to DDP. Pharmacogenomics and personalized medicine. 2023, 16: 1079-1089Cited : 1Read More
- 7)- Yi-Can Yang, Qiong Tang, Li-Juan Yan, Shi-Bin Zhang, Xiao-Min Ye, Dai Gong, Li Zou, Xiang-Lan Wen. A Case of Floating-Harbor Syndrome with "Growth and Language Development Delay" as Its Clinical Manifestation. Pharmacogenomics and personalized medicine. 2023, 16: 1091-1096Cited : 0Read More
- 8)- Priyanka Kolli, Grace Kelley, Marianela Rosales, Justin Faden, Ryan Serdenes. Olanzapine Pharmacokinetics: A Clinical Review of Current Insights and Remaining Questions. Pharmacogenomics and personalized medicine. 2023, 16: 1097-1108Cited : 1Read More
- 9)- Shimaa Aboelbaha, Monica Zolezzi, Oraib Abdallah, Yassin Eltorki. Mental Health Prescribers' Perceptions on the Use of Pharmacogenetic Testing in the Management of Depression in the Middle East and North Africa Region. Pharmacogenomics and personalized medicine. 2023, 16: 503-518Cited : 1Read More
- 10)- Xianhua Gu, Honghong Shen, Zheng Xiang, Xinwei Li, Yue Zhang, Rong Zhang, Fang Su, Zishu Wang. Exploring the Correlation Between , a Potential Target Gene of Gastric Cancer, and Immune Cell Infiltration. Pharmacogenomics and personalized medicine. 2023, 16: 519-535Cited : 0Read More
- 11)- Zhifei Hou, Xinran Zhang, Yong Gao, Jing Geng, Yu Jiang, Huaping Dai, Chen Wang. Serum Osteopontin, KL-6, and Syndecan-4 as Potential Biomarkers in the Diagnosis of Coal Workers' Pneumoconiosis: A Case-Control Study. Pharmacogenomics and personalized medicine. 2023, 16: 537-549Cited : 1Read More
- 12)- Qian Ma, Lei Chang, Wenwen Wang, Lingyi Che, Xiaoqin Song, Gailing Li, Ying Zhang, Yibing Chen, Zhuoyu Gu, Xin Ge. Leucyl and Cystinyl Aminopeptidase as a Prognostic-Related Biomarker in OV Correlating with Immune Infiltrates. Pharmacogenomics and personalized medicine. 2023, 16: 551-568Cited : 0Read More
- 13)- Mir Sadat-Ali, Hussain K Al-Omar, Khalid W AlTabash, Ammar K AlOmran, Dakheel A AlDakheel, Hasan N AlSayed. Genetic Influence of Fracture Nonunion (FNU): A Systematic Review. Pharmacogenomics and personalized medicine. 2023, 16: 569-575Cited : 0Read More
- 14)- Xiaoxia Wang, Haining Fang. Clinical and Gene Analysis of Fatty Acid Oxidation Disorders Found in Neonatal Tandem Mass Spectrometry Screening. Pharmacogenomics and personalized medicine. 2023, 16: 577-587Cited : 0Read More
- 15)- Enqi Zheng, Deshuang Xiao. Exploration into Plasma Hsa_circ_0052184 as a New Biomarker of Colorectal Cancer Prognosis. Pharmacogenomics and personalized medicine. 2023, 16: 589-597Cited : 0Read More
- 16)- Kang Huang, Tianyi Ma, Qiang Li, Yilei Zhou, Ting Qin, Zanrui Zhong, Shilin Tang, Wei Zhang, Jianghua Zhong, Shijuan Lu. Genetic Variants of Associated with Ischemic Stroke Susceptibility in the Han Population from Southern China. Pharmacogenomics and personalized medicine. 2023, 16: 599-607Cited : 0Read More
- 17)- Li Zhao, Zhenguo Zhai, Pengmei Li. One Rare Warfarin Resistance Case and Possible Mechanism Exploration. Pharmacogenomics and personalized medicine. 2023, 16: 609-615Cited : 3Read More
- 18)- Pingyi Wang, Hongyan Lu, Hao Rong, Yuhe Wang, Li Wang, Xue He, Dongya Yuan, Yongjun He, Tianbo Jin. The Association of Methylation Level in the Gene with High Altitude Pulmonary Edema in the Chinese Population. Pharmacogenomics and personalized medicine. 2023, 16: 617-628Cited : 0Read More
- 19)- Danya Zhao, Danping Qin, Liming Yin, Qiang Yang. Integrated Bioinformatics Analysis and Experimental Verification of Immune Cell Infiltration and the Related Core Genes in Ulcerative Colitis. Pharmacogenomics and personalized medicine. 2023, 16: 629-643Cited : 1Read More
- 20)- Eda Eken, David S Estores, Emily J Cicali, Kristin K Wiisanen, Julie A Johnson. A Pharmacogenetics-Based Approach to Managing Gastroesophageal Reflux Disease: Current Perspectives and Future Steps. Pharmacogenomics and personalized medicine. 2023, 16: 645-664Cited : 1Read More
- 21)- Beibei Wang, Linlin Huang, Shanliang Ye, Zhongwen Zheng, Shanying Liao. Identification of Novel Prognostic Biomarkers That are Associated with Immune Microenvironment Based on GABA-Related Molecular Subtypes in Gastric Cancer. Pharmacogenomics and personalized medicine. 2023, 16: 665-679Cited : 1Read More
- 22)- Danya F Vears, Julian Savulescu, John Christodoulou, Meaghan Wall, Ainsley J Newson. Are We Ready for Whole Population Genomic Sequencing of Asymptomatic Newborns? Pharmacogenomics and personalized medicine. 2023, 16: 681-691Cited : 5Read More
- 23)- Anna Bollinger, Céline K Stäuble, Chiara Jeiziner, Florine M Wiss, Kurt E Hersberger, Markus L Lampert, Henriette E Meyer Zu Schwabedissen, Samuel S Allemann. Genotyping of Patients with Adverse Drug Reaction or Therapy Failure: Database Analysis of a Pharmacogenetics Case Series Study. Pharmacogenomics and personalized medicine. 2023, 16: 693-706Cited : 0Read More
- 24)- Mingjun Hu, Jie Wei, Jie Hao, Tianbo Jin, Bin Li. Impact of Variants on the Risk and Prognosis of Glioma in the Chinese Han Population. Pharmacogenomics and personalized medicine. 2023, 16: 707-715Cited : 0Read More
- 25)- Fan Zhang, Hao Peng, Chuanyi Fu, Yidong Deng, Mao Zhang, Wenan Li, Jian Zhong, Qing Zhou, Li Huang, Shuli Xiao, Jiannong Zhao. Association Between and Gene Polymorphisms and Stroke Susceptibility in the Chinese Han Population. Pharmacogenomics and personalized medicine. 2023, 16: 717-727Cited : 0Read More
- 26)- James C Coons, Philip E Empey. Pharmacogenomics in the Management of Pulmonary Arterial Hypertension: Current Perspectives. Pharmacogenomics and personalized medicine. 2023, 16: 729-737Cited : 0Read More
- 27)- Cristina Montrasio, Stefania Cheli, Emilio Clementi. Pharmacogenetic Practice of Anticancer Drugs: Multiple Approaches for an Accurate and Comprehensive Genotyping. Pharmacogenomics and personalized medicine. 2023, 16: 739-746Cited : 3Read More
- 28)- Wei Huang, Zhengtao Qian, Yuxin Shi, Zheming Zhang, Rui Hou, Jie Mei, Junying Xu, Junli Ding. PSMC2 is a Novel Prognostic Biomarker and Predicts Immunotherapeutic Responses: From Pancreatic Cancer to Pan-Cancer. Pharmacogenomics and personalized medicine. 2023, 16: 747-758Cited : 0Read More
- 29)- Jiangfen Wu, Lingyan Ren, Xinyi Huang, Li Hu, Liangliang Zhang, Dan Xie, Zhimin Li, Naijian Han, Shengwen Huang. Identification of Two Novel Variants of the Gene in Chinese Families with Duchenne Muscular Dystrophy. Pharmacogenomics and personalized medicine. 2023, 16: 759-766Cited : 0Read More
- 30)- Yu-Qing Sun, Qiang Lv, Dong Chen, Yuwei Da, Xiao-Yan Zhao, Jian-Zeng Dong. A Case Study and Literature Review of the Diagnosis of Danon Disease in Patients Presenting Only with Severe Cardiac Symptoms. Pharmacogenomics and personalized medicine. 2023, 16: 767-775Cited : 0Read More
- 31)- Xiao Han, Qianjuan Zhang, Chengcheng Wang, Bingjuan Han. Clinical Characteristics and Novel Gene Mutation Analysis of Three Chinese Patients with Mowat-Wilson Syndrome. Pharmacogenomics and personalized medicine. 2023, 16: 777-783Cited : 0Read More
- 32)- Jia Huang, Haiyan Wu, Guiqiang Zhao, Yan Ma, Yunping An, Li Sun, Fuye Li, Shengling Wang. A Case-Control Study of the Relationship Between Genetic Polymorphism and Cretinism in Xinjiang. Pharmacogenomics and personalized medicine. 2023, 16: 785-794Cited : 0Read More
- 33)- Xin Jing, Yuhui Yun, Xiang Ji, Ende Yang, Pei Li. Pyroptosis and Inflammasome-Related Genes- and Polymorphisms Were Associated with Risk of Lung Cancer. Pharmacogenomics and personalized medicine. 2023, 16: 795-804Cited : 1Read More
- 34)- Shaofeng Xia, Chenliang Wang. Hsa_circ_0003489 Drives PTX Resistance of Human NSCLC Cells Through Modulating miR-98-5p/IGF2. Pharmacogenomics and personalized medicine. 2023, 16: 805-815Cited : 0Read More
- 35)- Qiong Tang, Dai Gong, Xiao-Min Ye, Jun-Ru Xu, Yi-Can Yang, Li-Juan Yan, Li Zou, Xiang-Lan Wen. A Case Report of Cardiofaciocutaneous Syndrome with Pathogenic Variant. Pharmacogenomics and personalized medicine. 2023, 16: 817-823Cited : 1Read More
- 36)- Ying-Yan Zhou, Jing-Hua Sun, Li Wang, Yan-Yan Cheng. Genetic Polymorphism of NQO1 Influences Susceptibility to Coronary Heart Disease in a Chinese Population: A Cross-Sectional Study and Meta-Anaylsis. Pharmacogenomics and personalized medicine. 2023, 16: 825-833Cited : 0Read More
- 37)- Haiyan He, Hang Ma, Zhuo Chen, Jingliang Chen, Dandan Wu, Xuedong Lv, Jie Zhu. Chromosomal Copy Number Variation Predicts EGFR-TKI Response and Prognosis for Patients with Non-Small Cell Lung Cancer. Pharmacogenomics and personalized medicine. 2023, 16: 835-846Cited : 0Read More
- 38)- Yazun Jarrar, Sara Abudahab, Ghasaq Abdul-Wahab, Dana Zaiter, Abdalla Madani, Sara J Abaalkhail, Dina Abulebdah, Hussam Alhawari, Rami Musleh, Su-Jun Lee. Clinical Significance of NAT2 Genetic Variations in Type II Diabetes Mellitus and Lipid Regulation. Pharmacogenomics and personalized medicine. 2023, 16: 847-857Cited : 1Read More
- 39)- Sarah Albogami. Genome-Wide Identification of lncRNA and mRNA for Diagnosing Type 2 Diabetes in Saudi Arabia. Pharmacogenomics and personalized medicine. 2023, 16: 859-882Cited : 0Read More
- 40)- Deepa Selvi Rani, Apoorva Kasala, Perundurai S Dhandapany, Uthiralingam Muthusami, Sreejith Kunnoth, Andiappan Rathinavel, Dharma Rakshak Ayapati, Kumarasamy Thangaraj. Novel Mutations in Indian Population with Cardiomyopathies. Pharmacogenomics and personalized medicine. 2023, 16: 883-893Cited : 0Read More
- 41)- Craig Brown, Jianhua Wang, Hong Jiang, Merrill F Elias. Homocysteine Reduction for Stroke Prevention: Regarding the Recent AHA/ASA 2021 Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack. Pharmacogenomics and personalized medicine. 2023, 16: 895-900Cited : 0Read More
- 42)- Ismail Mouhrach, Laila Bouguenouch, Adil Kamal, Abbassi Meriame, Nada El Khorb, Mohammed El Azami El Idrissi, Hafid Akoudad, Hicham Bekkari. Influence of CYP450 Enzymes and ABCB1 Polymorphisms on Clopidogrel Response in Moroccan Patients with Acute Coronary Syndromes. Pharmacogenomics and personalized medicine. 2023, 16: 901-909Cited : 0Read More
- 43)- Abdul Hadi Furqoni, Indah Fajarwati, Anna Lystia Poetranto. A Case Report of Cardiofaciocutaneous Syndrome with MAP2K1 Pathogenic Variant [Letter]. Pharmacogenomics and personalized medicine. 2023, 16: 911-912Cited : 0Read More
- 44)- Yu Zhou, Huoying Cai, Lin Huang, Mingshan Wang, Ruiming Liu, Siwen Wang, Yuansen Qin, Chen Yao, Zuojun Hu. Microarray Expression Profile and Bioinformatic Analysis of Circular RNA in Human Arteriosclerosis Obliterans. Pharmacogenomics and personalized medicine. 2023, 16: 913-924Cited : 0Read More
- 45)- Hu Yuan, Caihong Wang, Li Liu, Chun Wang, Zhenlin Zhang, Shen Qu. Association Between Gene Polymorphisms and Response to Alendronate Treatment in Postmenopausal Chinese Women with Low Bone Mineral Density. Pharmacogenomics and personalized medicine. 2023, 16: 925-932Cited : 0Read More
- 46)- Jie Dai, Shao Zhang, Yuhan Shi, Jinmei Xu, Weipeng Liu, Jia Yang, Li Shi, Zhiling Yan, Chuanyin Li. rs217727 of lncRNA H19 is Associated with Cervical Cancer Risk in the Chinese Han Population. Pharmacogenomics and personalized medicine. 2023, 16: 933-948Cited : 1Read More
- 47)- Junjie Chen, Xiwen Liao, Yining Wu, Shenjian Ou, Wei Qin, Chengkun Yang, Yufeng Tan, Quan Lao, Minhao Peng, Tao Peng, Xinping Ye. Hepatic Artery Infusion Chemotherapy Sequential Hepatic Artery Embolization Combined with Operation in the Treatment of Recurrent Massive Hepatocellular Carcinoma Achieved Pathological Complete Response: A Case Report. Pharmacogenomics and personalized medicine. 2023, 16: 949-958Cited : 0Read More
- 48)- Guo-Yi Shen, Peng-Jie Yang, Wen-Shan Zhang, Jun-Biao Chen, Qin-Yong Tian, Yi Zhang, Bater Han. Identification of a Prognostic Gene Signature Based on Lipid Metabolism-Related Genes in Esophageal Squamous Cell Carcinoma. Pharmacogenomics and personalized medicine. 2023, 16: 959-972Cited : 0Read More
- 49)- Angelo Oliva, Davide Cao, Alessandro Spirito, Johny Nicolas, Brunna Pileggi, Karim Kamaleldin, Birgit Vogel, Roxana Mehran. Personalized Approaches to Antiplatelet Treatment for Cardiovascular Diseases: An Umbrella Review. Pharmacogenomics and personalized medicine. 2023, 16: 973-990Cited : 0Read More
- 50)- Hao Qiao, Huanting Li. PLP2 Could Be a Prognostic Biomarker and Potential Treatment Target in Glioblastoma Multiforme. Pharmacogenomics and personalized medicine. 2023, 16: 991-1009Cited : 0Read More
